26. March 2018

The completed analysis, performed by GlobalData, a data and analytics company, reveals a number of interesting insights. The pharma sector’s 2017 v 2016 year on year performance inevitably created a mixed picture, with only half of the top 25 companies’ market cap achieving double digit growth and five players, Merck US, Celgene, GlaxoSmithKline, Allergan and Shire seeing their market cap fall. However, based on market cap J&J, Roche and Pfizer retained market position among the top...

03. March 2018

The year started with big bang M&A deals and was the most active January for deal making in over a decade with Sanofi and Celgene dominating the headlines. French drugmaker Sanofi started off by announcing it had closed a deal to acquire Biogen spinout Bioverativ, a maker of drugs for hemophilia, for almost US$ 11.6 billion.